secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001213900-24-060128
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX shareholders OK 750M authorized shares, reverse split up to 1:10
----------------------------------------------------------------------

- Authorized common shares increased from 120M to 750M, a 6.25x expansion.
- Board authorized reverse stock split at ratio 1:5 to 1:10, effective before July 9, 2025.
- A&R 2019 LTIP approved with 78M shares initial reserve plus annual 4% evergreen.
- Conversion of 256,887 Series X Preferred shares and related warrants into common approved.
- Alan Moses and Edward Williams elected as Class I directors until 2027 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390024060128/0001213900-24-060128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390024060128/ea0209083-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-060128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer